With gene editing tools becoming advanced enough to realise therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies.
Last Year's Event Included...
Over 800 attendees representing internationally renowned academic institutions, research institutes and hospitals as well as global pharmaceutical organisations and leading biotech companies.
Over 30 case studies, presentations, panel discussions focused on the key issues in advanced genome editing technologies, utilizing gene editing in drug discovery & development and therapeutics case studies from the areas of cystic fibrosis, neurodegenerative diseases and immunological and congenital disorders.
PLUS interactive opportunities including:
- Panel Discussions
- Pre-Event Webinars
- Pre-Event Speaker Q&As and Spotlights
Agenda at a Glance
Pre-Event Deep Dive Sessions